- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
RVAC Medicines arms itself with funding
GS Group contributed to a series B round that pushed messenger RNA therapeutics and vaccine developer RVAC Medicines' overall funding to $140m.
Apr 28, 2022Ayar Labs arrows to $130m series C
HPE, Nvidia, GlobalFoundries, Intel Capital, Applied Ventures and Lockheed Martin Ventures helped push the semiconductor technology provider's total funding past $190m.
Apr 28, 2022Q&A: Catching the next wave for a better future
Kaloyan Andonov spoke to Anil Achyuta, investment director of TDK Ventures – the venturing arm of the Japan-based materials group TDK – about the role of advanced materials in decarbonisation, electrification, 3D printing and battery recycling
Apr 28, 2022Embracing the circular economy for a cleaner Earth
Global Energy Council Q2 2022 editorial by James Mawson, editor in chief, Global Corporate Venturing
Apr 28, 2022Daily Deal Round Up: April 27, 2022
Corporate-backed medical imaging technology producer Lunit is preparing to float in South Korea while cancer drug developer Pheast secured $76m from investors including Alexandria Venture Investments.
Apr 27, 2022MassMutual Ventures assembles $300m fund
Massachusetts Mutual Life's venture capital arm has formed a fourth fund, which will concentrate on European and Asia-Pacific investments.
Apr 27, 2022Biofourmis takes care with $300m series D
CVS Health joined returning backers that could include SoftBank Vision Fund 2, MassMutual Ventures, Jianke and Aviva in a round valuing the digital care service at $1.3bn.
Apr 27, 2022Fu-Gen energises itself with $343m
Migdal and Menora Mivtachim helped supply the renewable energy infrastructure developer with fresh funding which will help expand its operations in the UK and Finland.
Apr 27, 2022Harness pulls in $230m
ServiceNow, Capital One Ventures, Citi Ventures, Splunk Ventures and GV all contributed to the software deployment technology provider's latest round, valuing it at $3.7bn.
Apr 27, 2022Dingreville lands at BP Launchpad
Sophie Dingreville, formerly of Munich Re Ventures, has been appointed chief investment officer of BP's digital technology accelerator.
Apr 27, 2022Daily Deal Round Up: April 26, 2022
Yangtze River Pharmaceutical Group led Binhui Biopharm's $47m series B-plus round while Sigfox has been snapped up by UnaBiz for under $30m after raising over $300m.
Apr 26, 2022Featured Content
GCV Powerlist 2026Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.GCV Powerlist 2026
Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
